Voting Member of American Urological Association
Dr. Ivan Aguilar, the Founder and CEO of the Mexico Transgender Center (MTC), is an internationally recognized leader in the field of Gender Reassignment Surgery. A board-certified urological surgeon, Dr. Aguilar possesses a unique and highly specialized background in Reconstructive Urology, Neuro-urology, and Pediatric Urology.
A true trailblazer in medical innovation, Dr. Aguilar was the first urologist in Mexico to implement Botulinum Toxin (BOTOX) for complex bladder and pelvic floor pathologies. His contributions to the field are further distinguished by his role as the inventor of a groundbreaking BOTOX-based treatment for premature ejaculation and the developer of PeniFlex™, a revolutionary penile enlargement implant. At MTC, Dr. Aguilar combines advanced urological precision with a deep commitment to the transgender community.
Board Certifications & Memberships
Board Certification: He is a board-certified urological surgeon.
Professional Affiliation: He is a Voting Member of the American Urological Association.
Education & Academic Background
Medical Training: He graduated as a Medical Surgeon (Médico Cirujano) from the Autonomous University of Sinaloa (Universidad Autónoma de Sinaloa). His Professional License (Cédula Profesional) number is 2775015.
Specialty Training: He completed his Urology specialty at the University of Guadalajara (Universidad de Guadalajara), training at the prestigious Centro Médico Nacional de Occidente. His Specialty License (Cédula Especialidad) number is 4512118.
Subspecialty & Reconstructive Training: He completed subspecialties in Pediatric and Gynecological Urology at the UCLA Medical Center under Dr. Shlomo Raz, along with an intensive surgical observership in gender-affirming surgery under renowned transgender surgeon Dr. Marci Bowers. Additionally, he completed postgraduate training in reconstructive urology in Arezzo, Italy, under Dr. Guido Barbagli, and at the institute of genitourinary reconstructive surgery in Seoul, South Korea, under Dr. Kim Jin Hong.
Professional Experience & Surgical Expertise
Leadership: He is the Founder and CEO of the Mexico Transgender Center (MTC). He is also the founder of Men’s Clinic, a facility dedicated exclusively to urology and men’s health.
Core Specialties: He specializes in Reconstructive Urology, Neuro-urology, Pediatric Urology, and Gender Reassignment Surgery.
Medical Innovations: He was the first urologist in Mexico to utilize Botulinum Toxin (BOTOX) for prostate and bladder pathologies, pelvic floor diseases, and incontinence. Furthermore, he is the inventor of a BOTOX-based treatment for premature ejaculation and the developer of PeniFlex™, a penile enlargement implant.
